Loading…
Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis
Background Untreated glycogen storage disease (GSD)‐1a patients experience hypoglycaemia and growth retardation. The present study examined the effects of dietary interventions on the maintenance of normoglycaemia. Methods Clinical trials were identified from EMBASE (January 1980 to November 2011),...
Saved in:
Published in: | Journal of human nutrition and dietetics 2013-08, Vol.26 (4), p.329-339 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Untreated glycogen storage disease (GSD)‐1a patients experience hypoglycaemia and growth retardation. The present study examined the effects of dietary interventions on the maintenance of normoglycaemia.
Methods
Clinical trials were identified from EMBASE (January 1980 to November 2011), MEDLINE (January 1948 to November 2011) and the Cochrane Central Register of Controlled Trials (2011, Issue 4). The intermittent administration of uncooked cornstarch was compared with: (i) continuous nocturnal feeding of dextrose; (ii) modified uncooked cornstarch; and (iii) dextrose and an uncooked cornstarch–dextrose mixture. One author extracted the data, and assessed the trial eligibility and risk of bias. Quality assessment and data extraction were conducted and checked independently.
Results
Of 41 articles retrieved, five controlled trials (49 participants) were identified with follow‐up at 2 days to 14 years. Results from three nonrandomised controlled trials comparing uncooked cornstarch with continuous nocturnal feeding of dextrose were pooled in a meta‐analysis based on a fixed‐effect model. Twenty‐six participants (three trials) receiving uncooked cornstarch showed a significant increase in blood glucose concentration: mean difference (MD) 0.62 mmol L−1 [95% confidence interval (CI) = 0.23–1.00] (P = 0.002), 21 (two trials) increased serum insulin: MD 62.37 pmol L−1 (95% CI = 32.19–92.55) (P |
---|---|
ISSN: | 0952-3871 1365-277X |
DOI: | 10.1111/jhn.12030 |